A randomized phase II trial of single-agent gemcitabine, vinorelbine, or docetaxel in patients with advanced non-small cell lung cancer who have poor performance status and/or are elderly.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples